Elanco Animal Health (ELAN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Group 1 - Elanco Animal Health reported $1.02 billion in revenue for Q4 2024, a year-over-year decline of 1.5% [1] - The EPS for the same period was $0.14, compared to $0.08 a year ago, indicating an increase [1] - The revenue exceeded the Zacks Consensus Estimate of $1.01 billion by 0.83%, while the EPS fell short of the consensus estimate of $0.15 by 6.67% [1] Group 2 - Total Pet Health revenue was $439 million, surpassing the average estimate of $428.67 million, reflecting a year-over-year increase of 5.5% [4] - Total Contract Manufacturing revenue reached $11 million, exceeding the average estimate of $9.35 million, with a year-over-year growth of 22.2% [4] - Total Farm Animal revenue was $570 million, slightly below the average estimate of $575.40 million, showing a year-over-year decline of 6.6% [4] Group 3 - Elanco Animal Health shares have returned -8% over the past month, compared to the Zacks S&P 500 composite's -1.8% change [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]